Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

20 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:39 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase not reported / not applicableRecruitingOBSERVATIONAL

Evaluation of 25(OH)D3 and LL-37 Levels in Periimplant Sulcus Fluid

ClinicalTrials.gov · NCT07280754 · Registry updated: 2026-11-03

Condition / research focus: Peri Implantitis; Peri Implant Mucositis
Sponsor: Recep Tayyip Erdogan University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-12-30. Completion: 2027-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Recep Tayyip Erdoğan University
Rize, Islampasa Street, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

ClinicalTrials.gov · NCT05054361 · Registry updated: 2026-10-27

Condition / research focus: Type1diabetes
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Countries with listed sites: France
Registry dates and results: Start: 2022-02-14. Completion: 2027-08-14 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MAIT cells analysis (diagnostic_test)
MAIT cytokines production analysis (diagnostic_test)
Lactulose/Mannitol Test (diagnostic_test)
UGI Endoscopy (procedure)
Coxsackie virus B infection status (diagnostic_test)
Coxsackie virus B infection status (diagnostic_test)

Where the study takes place — 2 listed sites

Hopital privé d'Antony
Antony, France
Site recruitment: Not yet recruiting
Hopital Necker enfants malades
Paris, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Peri-implant Vitamin D and Cathelicidin (LL-37) Levels

ClinicalTrials.gov · NCT06867250 · Registry updated: 2025-03-10

Condition / research focus: Peri-Implantitis and Peri-implant Mucositis
Sponsor: Altinbas University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2021-04-01. Completion: 2021-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

The patients' periodontal clinical parameters were recorded. PISF samples were collected, and the evaluations of 25(OH)D and LL-37 were conducted using enzyme-linked immunosorbent assay. (diagnostic_test)

Where the study takes place — 1 listed sites

Altinbas University
Istanbul, BAKIRKOy, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Cathelicidin LL-37 Relation to Potentially Malignant Lesions

ClinicalTrials.gov · NCT06219330 · Registry updated: 2024-01-23

Condition / research focus: Oral Potentially Malignant Lesions
Sponsor: Fayoum University
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-07-01. Completion: 2023-11-15 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Sandy hassan shaaban
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

The Role of Anti-inflammatory Cytokines and Antimicrobial Peptide LL-37 Biomarkers in the Treatment of Periodontal Disease.

ClinicalTrials.gov · NCT04404335 · Registry updated: 2022-09-30

Condition / research focus: Periodontal Diseases; Periodontitis
Sponsor: Universidad Rey Juan Carlos
Countries with listed sites: Spain
Registry dates and results: Start: 2021-05-17. Completion: 2022-07-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Crevicular fluid analysis by using ELISA testing. (diagnostic_test)

Where the study takes place — 1 listed sites

Clinica Universitaria Universidad Rey Juan Carlos
Alcorcón, Madrid, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Intratumoral Injections of LL37 for Melanoma

ClinicalTrials.gov · NCT02225366 · Registry updated: 2021-12-09

Condition / research focus: Melanoma
Sponsor: M.D. Anderson Cancer Center
Countries with listed sites: United States
Registry dates and results: Start: 2015-07-08. Completion: 2020-11-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LL37 (biological)
Photographs (other)

Where the study takes place — 1 listed sites

University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.

ClinicalTrials.gov · NCT02806414 · Registry updated: 2021-10-05

Condition / research focus: Rosacea
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2016-07. Completion: 2021-05 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ivermectin (drug) — also listed as: Soolantra

Where the study takes place — 1 listed sites

UCSD Division of Dermatology
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels

ClinicalTrials.gov · NCT04946617 · Registry updated: 2021-07-01

Condition / research focus: Mouth and Tooth Diseases; Periodontal Diseases; Gingivitis
Sponsor: Istanbul Medeniyet University
Countries with listed sites: No country reported
Registry dates and results: Start: 2021-07-20. Completion: 2021-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

undefined (drug) — also listed as: Mouthwash Product

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis

ClinicalTrials.gov · NCT04861493 · Registry updated: 2021-04-27

Condition / research focus: Smoking Reduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-02-23. Completion: 2021-04-15 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Faculty of dentistry cairo university
Al Manyal, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1TerminatedINTERVENTIONAL

Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV

ClinicalTrials.gov · NCT03270709 · Registry updated: 2021-04-21

Condition / research focus: HIV/AIDS; Vitamin D Deficiency; Smoker Lung
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2018-04-11. Completion: 2018-10-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vitamin D3 450,000 IU orally (drug)

Where the study takes place — 2 listed sites

Atlanta VA Medical center
Atlanta, Georgia, United States
Site recruitment: Not reported
Grady Health System (non-CRN), Grady Health System (CRN), Ponce Center
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children

ClinicalTrials.gov · NCT04292548 · Registry updated: 2020-03-03

Condition / research focus: Passive Smoking; Oxidative Stress; Dental Caries; Children
Sponsor: Merve Erkmen Almaz
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-11-16. Completion: 2018-08-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

taking saliva samples to determine TAS, TOS and LL-37 (diagnostic_test)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers

ClinicalTrials.gov · NCT04098562 · Registry updated: 2019-09-25

Condition / research focus: Diabetic Foot Ulcer
Sponsor: Fakultas Kedokteran Universitas Indonesia
Countries with listed sites: Indonesia
Registry dates and results: Start: 2019-10. Completion: 2020-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LL37 (drug)
Standard Wound Care (procedure)

Where the study takes place — 3 listed sites

RS Persahabatan
Jakarta, DKI Jakarta, Indonesia
Site recruitment: Not reported
RS Pusat Angkatan Darat Gatot Soebroto
Jakarta Pusat, DKI Jakarta, Indonesia
Site recruitment: Not reported
RSUPN dr. Cipto Mangunkusumo
Jakarta Pusat, DKI Jakarta, Indonesia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation

ClinicalTrials.gov · NCT01398280 · Registry updated: 2019-09-13

Condition / research focus: Rosacea
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2012-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Topical aminocaproic acid (ACA) mixed with Vanicream (drug)
Vehicle cream (drug)

Where the study takes place — 1 listed sites

University of California, San Diego Perlman Ambulatory Center
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37

ClinicalTrials.gov · NCT03923218 · Registry updated: 2019-04-22

Condition / research focus: Periodontitis
Sponsor: Gazi University
Countries with listed sites: No country reported
Registry dates and results: Start: 2011-12. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LL-37 levels in Gingival crevicular fluid (other)
Serum Vitamin D3 levels (other)
Clinical parameters (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Passive Smoking and LL-37 in Children

ClinicalTrials.gov · NCT03639376 · Registry updated: 2018-08-21

Condition / research focus: Innate Immunity; Periodontal Health
Sponsor: Kırıkkale University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-11. Completion: 2018-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3WithdrawnINTERVENTIONAL

Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.

ClinicalTrials.gov · NCT02138591 · Registry updated: 2017-06-16

Condition / research focus: Vitamin d Deficiency
Sponsor: University of Missouri, Kansas City
Countries with listed sites: United States
Registry dates and results: Start: 2016-02. Completion: 2016-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood draw pre-operatively (procedure) — also listed as: Venipuncture
Blood draw post-operative Day 1 (procedure) — also listed as: Venipuncture
Blood draw post-operative Day 2 (procedure) — also listed as: Venipuncture

Where the study takes place — 1 listed sites

Truman Medical Center Hospital Hill
Kansas City, Missouri, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients

ClinicalTrials.gov · NCT01858051 · Registry updated: 2017-03-30

Condition / research focus: Hypovitaminosis D
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2015-01. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cholecalciferol (dietary_supplement)
Placebo (dietary_supplement)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Vitamin D in Ventilated ICU Patients

ClinicalTrials.gov · NCT01372995 · Registry updated: 2017-01-09

Condition / research focus: Respiratory Failure
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2014-04 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Enteral Vitamin D3 50,000 IU (drug)
Enteral Vitamin D3 100,000IU (drug)
Inactive substance (other)

Where the study takes place — 2 listed sites

Emory University Hospital Midtown
Atlanta, Georgia, United States
Site recruitment: Not reported
Emory University Hospital
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Vitamin D in Active Tuberculosis (TB) Study

ClinicalTrials.gov · NCT00788320 · Registry updated: 2012-01-20

Condition / research focus: Tuberculosis
Sponsor: Atlanta VA Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-10. Completion: 2010-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vitamin D3 (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Therapeutic Induction of Endogenous Antibiotics

ClinicalTrials.gov · NCT00800930 · Registry updated: 2011-12-08

Condition / research focus: Shigellosis
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2005-01. Completion: 2009-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sodium Butyrate (biological)
Saline (biological)

Where the study takes place — 2 listed sites

Dhaka Hospital & Matlab Hospital
Dhaka, Bangladesh
Site recruitment: Not reported
ICDDR,B
Dhaka, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

20 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:39 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase not reported / not applicableRecruitingOBSERVATIONAL

Evaluation of 25(OH)D3 and LL-37 Levels in Periimplant Sulcus Fluid

ClinicalTrials.gov · NCT07280754 · Registry updated: 2026-11-03

Condition / research focus: Peri Implantitis; Peri Implant Mucositis
Sponsor: Recep Tayyip Erdogan University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-12-30. Completion: 2027-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Recep Tayyip Erdoğan University
Rize, Islampasa Street, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children

ClinicalTrials.gov · NCT05054361 · Registry updated: 2026-10-27

Condition / research focus: Type1diabetes
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Countries with listed sites: France
Registry dates and results: Start: 2022-02-14. Completion: 2027-08-14 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MAIT cells analysis (diagnostic_test)
MAIT cytokines production analysis (diagnostic_test)
Lactulose/Mannitol Test (diagnostic_test)
UGI Endoscopy (procedure)
Coxsackie virus B infection status (diagnostic_test)
Coxsackie virus B infection status (diagnostic_test)

Where the study takes place — 2 listed sites

Hopital privé d'Antony
Antony, France
Site recruitment: Not yet recruiting
Hopital Necker enfants malades
Paris, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Peri-implant Vitamin D and Cathelicidin (LL-37) Levels

ClinicalTrials.gov · NCT06867250 · Registry updated: 2025-03-10

Condition / research focus: Peri-Implantitis and Peri-implant Mucositis
Sponsor: Altinbas University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2021-04-01. Completion: 2021-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

The patients' periodontal clinical parameters were recorded. PISF samples were collected, and the evaluations of 25(OH)D and LL-37 were conducted using enzyme-linked immunosorbent assay. (diagnostic_test)

Where the study takes place — 1 listed sites

Altinbas University
Istanbul, BAKIRKOy, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Cathelicidin LL-37 Relation to Potentially Malignant Lesions

ClinicalTrials.gov · NCT06219330 · Registry updated: 2024-01-23

Condition / research focus: Oral Potentially Malignant Lesions
Sponsor: Fayoum University
Countries with listed sites: Egypt
Registry dates and results: Start: 2023-07-01. Completion: 2023-11-15 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Sandy hassan shaaban
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

The Role of Anti-inflammatory Cytokines and Antimicrobial Peptide LL-37 Biomarkers in the Treatment of Periodontal Disease.

ClinicalTrials.gov · NCT04404335 · Registry updated: 2022-09-30

Condition / research focus: Periodontal Diseases; Periodontitis
Sponsor: Universidad Rey Juan Carlos
Countries with listed sites: Spain
Registry dates and results: Start: 2021-05-17. Completion: 2022-07-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Crevicular fluid analysis by using ELISA testing. (diagnostic_test)

Where the study takes place — 1 listed sites

Clinica Universitaria Universidad Rey Juan Carlos
Alcorcón, Madrid, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Intratumoral Injections of LL37 for Melanoma

ClinicalTrials.gov · NCT02225366 · Registry updated: 2021-12-09

Condition / research focus: Melanoma
Sponsor: M.D. Anderson Cancer Center
Countries with listed sites: United States
Registry dates and results: Start: 2015-07-08. Completion: 2020-11-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LL37 (biological)
Photographs (other)

Where the study takes place — 1 listed sites

University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.

ClinicalTrials.gov · NCT02806414 · Registry updated: 2021-10-05

Condition / research focus: Rosacea
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2016-07. Completion: 2021-05 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ivermectin (drug) — also listed as: Soolantra

Where the study takes place — 1 listed sites

UCSD Division of Dermatology
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels

ClinicalTrials.gov · NCT04946617 · Registry updated: 2021-07-01

Condition / research focus: Mouth and Tooth Diseases; Periodontal Diseases; Gingivitis
Sponsor: Istanbul Medeniyet University
Countries with listed sites: No country reported
Registry dates and results: Start: 2021-07-20. Completion: 2021-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

undefined (drug) — also listed as: Mouthwash Product

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis

ClinicalTrials.gov · NCT04861493 · Registry updated: 2021-04-27

Condition / research focus: Smoking Reduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-02-23. Completion: 2021-04-15 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Faculty of dentistry cairo university
Al Manyal, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1TerminatedINTERVENTIONAL

Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV

ClinicalTrials.gov · NCT03270709 · Registry updated: 2021-04-21

Condition / research focus: HIV/AIDS; Vitamin D Deficiency; Smoker Lung
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2018-04-11. Completion: 2018-10-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vitamin D3 450,000 IU orally (drug)

Where the study takes place — 2 listed sites

Atlanta VA Medical center
Atlanta, Georgia, United States
Site recruitment: Not reported
Grady Health System (non-CRN), Grady Health System (CRN), Ponce Center
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children

ClinicalTrials.gov · NCT04292548 · Registry updated: 2020-03-03

Condition / research focus: Passive Smoking; Oxidative Stress; Dental Caries; Children
Sponsor: Merve Erkmen Almaz
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-11-16. Completion: 2018-08-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

taking saliva samples to determine TAS, TOS and LL-37 (diagnostic_test)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers

ClinicalTrials.gov · NCT04098562 · Registry updated: 2019-09-25

Condition / research focus: Diabetic Foot Ulcer
Sponsor: Fakultas Kedokteran Universitas Indonesia
Countries with listed sites: Indonesia
Registry dates and results: Start: 2019-10. Completion: 2020-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LL37 (drug)
Standard Wound Care (procedure)

Where the study takes place — 3 listed sites

RS Persahabatan
Jakarta, DKI Jakarta, Indonesia
Site recruitment: Not reported
RS Pusat Angkatan Darat Gatot Soebroto
Jakarta Pusat, DKI Jakarta, Indonesia
Site recruitment: Not reported
RSUPN dr. Cipto Mangunkusumo
Jakarta Pusat, DKI Jakarta, Indonesia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation

ClinicalTrials.gov · NCT01398280 · Registry updated: 2019-09-13

Condition / research focus: Rosacea
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2012-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Topical aminocaproic acid (ACA) mixed with Vanicream (drug)
Vehicle cream (drug)

Where the study takes place — 1 listed sites

University of California, San Diego Perlman Ambulatory Center
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37

ClinicalTrials.gov · NCT03923218 · Registry updated: 2019-04-22

Condition / research focus: Periodontitis
Sponsor: Gazi University
Countries with listed sites: No country reported
Registry dates and results: Start: 2011-12. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LL-37 levels in Gingival crevicular fluid (other)
Serum Vitamin D3 levels (other)
Clinical parameters (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Passive Smoking and LL-37 in Children

ClinicalTrials.gov · NCT03639376 · Registry updated: 2018-08-21

Condition / research focus: Innate Immunity; Periodontal Health
Sponsor: Kırıkkale University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-11. Completion: 2018-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3WithdrawnINTERVENTIONAL

Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.

ClinicalTrials.gov · NCT02138591 · Registry updated: 2017-06-16

Condition / research focus: Vitamin d Deficiency
Sponsor: University of Missouri, Kansas City
Countries with listed sites: United States
Registry dates and results: Start: 2016-02. Completion: 2016-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood draw pre-operatively (procedure) — also listed as: Venipuncture
Blood draw post-operative Day 1 (procedure) — also listed as: Venipuncture
Blood draw post-operative Day 2 (procedure) — also listed as: Venipuncture

Where the study takes place — 1 listed sites

Truman Medical Center Hospital Hill
Kansas City, Missouri, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients

ClinicalTrials.gov · NCT01858051 · Registry updated: 2017-03-30

Condition / research focus: Hypovitaminosis D
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2015-01. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cholecalciferol (dietary_supplement)
Placebo (dietary_supplement)

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Vitamin D in Ventilated ICU Patients

ClinicalTrials.gov · NCT01372995 · Registry updated: 2017-01-09

Condition / research focus: Respiratory Failure
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2014-04 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Enteral Vitamin D3 50,000 IU (drug)
Enteral Vitamin D3 100,000IU (drug)
Inactive substance (other)

Where the study takes place — 2 listed sites

Emory University Hospital Midtown
Atlanta, Georgia, United States
Site recruitment: Not reported
Emory University Hospital
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Vitamin D in Active Tuberculosis (TB) Study

ClinicalTrials.gov · NCT00788320 · Registry updated: 2012-01-20

Condition / research focus: Tuberculosis
Sponsor: Atlanta VA Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-10. Completion: 2010-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vitamin D3 (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Therapeutic Induction of Endogenous Antibiotics

ClinicalTrials.gov · NCT00800930 · Registry updated: 2011-12-08

Condition / research focus: Shigellosis
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2005-01. Completion: 2009-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sodium Butyrate (biological)
Saline (biological)

Where the study takes place — 2 listed sites

Dhaka Hospital & Matlab Hospital
Dhaka, Bangladesh
Site recruitment: Not reported
ICDDR,B
Dhaka, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →